Effect of Vimala Massage Versus Hydrotherapy on the Clinical Outcomes of Neonatal Hyperbilirubinemia
Launched by KAFRELSHEIKH UNIVERSITY · Sep 10, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how two different treatments—Vimala massage and hydrotherapy—can help newborns with jaundice, which is a common condition that causes yellowing of the skin and eyes due to high levels of bilirubin in the blood. The study aims to see which method works better in improving the health of these babies.
To participate, babies need to be full-term (born between 37 to 42 weeks), weigh at least 1500 grams, and have a good health score at birth. They should also be experiencing physiological jaundice and will receive light therapy during the study. However, babies with serious health issues, like heart problems or skin disorders, cannot join. Families can expect their infants to receive either the Vimala massage or hydrotherapy while being monitored for their health. This research is currently recruiting participants and is important for finding the best ways to treat neonatal jaundice effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • full-term neonates aged 37- 42 weeks of gestation with a birth weight of ≥1500 g and a five-minute Apgar score of seven or above. Furthermore, the newborn with physiological jaundice will be admitted for phototherapy from the first to the tenth day, and the infant's vital signs will remain normal
- Exclusion Criteria:
- • major congenital malformations, intestinal obstruction, congenital heart disease, sepsis, neonates with a disease that disrupts skin integrity (epidermolysis bullosa, ichthyosis, collodion baby).
About Kafrelsheikh University
Kafrelsheikh University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that contribute to the enhancement of healthcare practices and patient outcomes. With a strong emphasis on interdisciplinary collaboration, the university harnesses its diverse expertise in medical sciences, engineering, and technology to conduct rigorous clinical studies. Kafrelsheikh University aims to foster innovation in clinical research, ensuring compliance with ethical standards and regulatory requirements, while actively engaging in community health initiatives to address pressing health challenges. Through its commitment to excellence, the university seeks to develop evidence-based solutions that improve health and well-being at both local and global levels.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kafr Ash Shaykh, Kafr El Sheikh, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported